Transmedics Group Inc (TMDX) Stock Price, Quote & News

Company Profile

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of s...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 552 0900

Website: www.transmedics.com

Address:

200 Minuteman Road, Suite 302, Andover, United States

NeverPop Sep. 12 at 3:45 PM

$TMDX absolutely hates its 50day.

1 · Reply

marionil Sep. 11 at 11:15 PM

$TMDX their trial was approved

0 · Reply

Bamba1 Sep. 11 at 10:32 PM

$TMDX this stock is being manipulated I’m out

1 · Reply

TriGuy8542 Sep. 11 at 7:44 PM

$TMDX I hope OPEN changes real estate forever, but in case they don’t. I’m definitely making money here. Anyone in OPEN?

0 · Reply

Stoop_Kid Sep. 11 at 6:25 PM

$TMDX they think that medlogs 300k sq ft cold storage facility is so cool. Cold costs $. Normothermic tech :)

0 · Reply

Lambster2 Sep. 11 at 6:01 PM

$TMDX Talk about pegged. I predict mid 120s next week when this seller clears.

0 · Reply

JFDI Sep. 11 at 4:53 PM

$TMDX wide range igniting bar.

1 · Reply

Olddrache Sep. 11 at 4:21 PM

$TMDX moving

0 · Reply

TriGuy8542 Sep. 11 at 4:15 PM

$TMDX I’ve been feeling like such a moron for weeks now as I watch all things Ai related go up. I know there will be a massive pullback perhaps 2026-7, but in the meantime, wow! So then I think to TMDX growing at a rapid clip too and seeing no love while seeing massive bottom line strength. Odd times.

1 · Reply

SodApOp_PIMPski Sep. 11 at 3:38 PM

$TMDX great reversal

0 · Reply

TransMedics Group, Inc. (TMDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 3, 2025, 10:53 AM EDT - 11 days ago

TransMedics: Just Like The CEO, I'm Buying

Aug 25, 2025, 4:05 PM EDT - 20 days ago

TransMedics to Present at Upcoming September Investor Conferences

Aug 25, 2025, 3:36 AM EDT - 20 days ago

TransMedics: CEO Is Buying Shares Ahead Of A Potentially Concerning Q3

Aug 12, 2025, 8:00 PM EDT - 4 weeks ago

Technical Tuesday: SPX All-Time High, OKLO Bull Flags & TMDX Bullish SMA

OKLO

Aug 4, 2025, 8:00 AM EDT - 5 weeks ago

TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial

Aug 1, 2025, 4:05 PM EDT - 6 weeks ago

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Aug 1, 2025, 6:25 AM EDT - 6 weeks ago

TransMedics: Continued Strength Suggests Further Upside

Jul 31, 2025, 12:28 AM EDT - 6 weeks ago

TransMedics Group, Inc. (TMDX) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 4:05 PM EDT - 6 weeks ago

TransMedics Reports Second Quarter 2025 Financial Results

Jul 29, 2025, 4:05 PM EDT - 6 weeks ago

TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 25, 2025, 11:57 AM EDT - 7 weeks ago

Why TransMedics Remains A Buy Into 2026

Jul 23, 2025, 4:17 PM EDT - 7 weeks ago

This Company Transports Donated Organs. Its Stock Has Had a Roller-Coaster Ride.

Jul 16, 2025, 4:05 PM EDT - 2 months ago

TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

Jul 14, 2025, 12:27 AM EDT - 2 months ago

TransMedics: Q2 Analyst Estimates Will Fall Short

Jun 23, 2025, 10:00 AM EDT - 2 months ago

TransMedics' Turnaround: The Organ Transplant Leader Is Still A Buy

Jun 17, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect

Jun 15, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out

Jun 12, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation

Jun 10, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation

Jun 8, 2025, 10:00 AM EDT - 3 months ago

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 5, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect

Jun 1, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation

May 29, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Investors to Reach Out

May 27, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out

May 25, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect

May 22, 2025, 10:00 AM EDT - 4 months ago

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 21, 2025, 4:54 AM EDT - 4 months ago

TransMedics: Extremely Undervalued And Extremely Innovative

May 20, 2025, 4:05 PM EDT - 4 months ago

TransMedics to Present at Upcoming June Investor Conferences

May 13, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Shareholders to Learn More About the Investigation

May 11, 2025, 10:00 AM EDT - 4 months ago

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 9, 2025, 9:48 AM EDT - 4 months ago

TransMedics: Exceptional Q1 Undermines The Short Narrative

May 8, 2025, 10:40 PM EDT - 4 months ago

TransMedics Group, Inc. (TMDX) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 4 months ago

TransMedics Reports First Quarter 2025 Financial Results

Apr 24, 2025, 4:05 PM EDT - 5 months ago

TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 23, 2025, 4:23 AM EDT - 5 months ago

TransMedics: Get Some Exposure Despite Market Concerns

Apr 22, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation

Apr 11, 2025, 7:43 AM EDT - 5 months ago

TMDX STOCK FRAUD: Did TransMedics Group Commit Securities Fraud? Investors are Notified to Contact BFA Law by the April 15 Court Deadline (NASDAQ:TMDX)

Apr 11, 2025, 2:06 AM EDT - 5 months ago

DEADLINE NEXT WEEK: Berger Montague Advises TransMedics (NASDAQ: TMDX) Investors to Contact the Firm Before April 15, 2025

Apr 10, 2025, 7:00 PM EDT - 5 months ago

Investor Reminder (TMDX): Kessler Topaz Meltzer & Check, LLP Reminds TransMedics Group, Inc. Investors of April 15, 2025 Deadline

Apr 10, 2025, 3:38 PM EDT - 5 months ago

TMDX STOCK NOTICE: TransMedics Group is being Sued for Fraud – Investors with Losses are Reminded to Contact BFA Law by April 15 Deadline

NeverPop Sep. 12 at 3:45 PM

$TMDX absolutely hates its 50day.

1 · Reply

marionil Sep. 11 at 11:15 PM

$TMDX their trial was approved

0 · Reply

Bamba1 Sep. 11 at 10:32 PM

$TMDX this stock is being manipulated I’m out

1 · Reply

TriGuy8542 Sep. 11 at 7:44 PM

$TMDX I hope OPEN changes real estate forever, but in case they don’t. I’m definitely making money here. Anyone in OPEN?

0 · Reply

Stoop_Kid Sep. 11 at 6:25 PM

$TMDX they think that medlogs 300k sq ft cold storage facility is so cool. Cold costs $. Normothermic tech :)

0 · Reply

Lambster2 Sep. 11 at 6:01 PM

$TMDX Talk about pegged. I predict mid 120s next week when this seller clears.

0 · Reply

JFDI Sep. 11 at 4:53 PM

$TMDX wide range igniting bar.

1 · Reply

Olddrache Sep. 11 at 4:21 PM

$TMDX moving

0 · Reply

TriGuy8542 Sep. 11 at 4:15 PM

1 · Reply

SodApOp_PIMPski Sep. 11 at 3:38 PM

$TMDX great reversal

0 · Reply

YouAndUs Sep. 11 at 3:36 PM

$TMDX News?

0 · Reply

chrsc Sep. 11 at 3:35 PM

$TMDX nice move, clear path to $132 and then much higher from there.

0 · Reply

DKNGGUY Sep. 11 at 2:40 PM

$TMDX going back to 130 CEO wanted to buy more. Told to hold off.

0 · Reply

WeeklyOptionsTrading Sep. 11 at 2:37 PM

$TMDX shorts are toast!

0 · Reply

Dunkar Sep. 11 at 2:22 PM

$TMDX 122-125 should come easy

0 · Reply

Halo202 Sep. 11 at 2:15 PM

$TMDX Called it

1 · Reply

Lambster2 Sep. 11 at 2:10 PM

$TMDX I like the consolidation that's been happening at this level. Added today

0 · Reply

TriGuy8542 Sep. 10 at 8:01 PM

$TMDX WTF HCG 👇🏻 is now bullish? Well I’m glad he came around

1 · Reply

healthcareguru Sep. 10 at 7:01 PM

$TMDX sitting at an incredible 24% short interest of the float…this has SQUEEZE CITY written all over it… 🔥💪 $IWM $XBI $IHI $XLV

0 · Reply

sellthetop Sep. 10 at 6:46 PM

$TMDX this stock will be $200 this time next year.

0 · Reply

TriGuy8542 Sep. 10 at 1:48 PM

$TMDX Flight run rate this far is 27.2 flights per day. If we continue this rate we’ll cruise over Q1 and I better we beat estimates. I’d that happens Jonah’s target of 40% YoY growth will be hit. Incredible the market could care less for the name. Heart and lung trial growth will have to be the part that gets everyone jazzed up again.

0 · Reply

NeverPop Sep. 9 at 7:12 PM

$TMDX technically it’s allergic to the 50 day. And Mr. market is ignoring all the positive fundamental vibes!

0 · Reply

Market Cap	3.91B
Revenue (ttm)	441.54M
Net Income (ttm)	35.46M
EPS (ttm)	N/A
PE Ratio	60.62
Forward PE	50.00
Profit Margin	8.03%
Debt to Equity Ratio	0.19

Volume	793,900
Avg Vol	1,129,016
Day's Range	N/A - N/A
Shares Out	34.09M
Stochastic %K	74%
Beta	2.18
Analysts	Strong Sell
Price Target	$138.88